Vanguard Group’s Aevi Genomic Medicine Inc GNMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
|
|||||
2019
Q4 | $156K | Sell |
|
|||||
2019
Q3 | $232K | Buy |
|
|||||
2019
Q2 | $201K | Buy |
|
|||||
2019
Q1 | $134K | Sell |
|
|||||
2018
Q4 | $508K | Sell |
|
|||||
2018
Q3 | $1.21M | Buy |
|
|||||
2018
Q2 | $1.08M | Buy |
|
|||||
2018
Q1 | $1.9M | Buy |
|
|||||
2017
Q4 | $911K | Sell |
|
|||||
2017
Q3 | $1.21M | Sell |
|
|||||
2017
Q2 | $1.31M | Sell |
|
|||||
2017
Q1 | $2.31M | Buy |
|
|||||
2016
Q4 | $5.99M | Buy |
|
|||||
2016
Q3 | $6.03M | Buy |
|
|||||
2016
Q2 | $5.37M | Buy |
|
|||||
2016
Q1 | $3.6M | Buy |
|
|||||
2015
Q4 | $4.59M | Buy |
|
|||||
2015
Q3 | $4.78M | Buy |
|
|||||
2015
Q2 | $3.44M | Buy |
|
|||||
2015
Q1 | $4.06M | Buy |
|
|||||
2014
Q4 | $2.19M | Buy |
|
|||||
2014
Q3 | $1.88M | Buy |
|
|||||
2014
Q2 | $2.77M | Buy |
|
|||||
2014
Q1 | $2.36M | Buy |
|
|||||
2013
Q4 | $1.67M | Buy |
|
|||||
2013
Q3 | $1.33M | Buy |
|
|||||
2013
Q2 | $477K | Buy |
|